Your browser doesn't support javascript.
loading
The retinoblastoma tumor suppressor pathway modulates the invasiveness of ErbB2-positive breast cancer.
Witkiewicz, A K; Cox, D W; Rivadeneira, D; Ertel, A E; Fortina, P; Schwartz, G F; Knudsen, E S.
Afiliação
  • Witkiewicz AK; 1] Department of Pathology, UT Southwestern Medical Center, Dallas, TX, USA [2] Simmons Cancer Center, UT Southwestern Medical Center, Dallas, TX, USA.
  • Cox DW; Department of Pathology, UT Southwestern Medical Center, Dallas, TX, USA.
  • Rivadeneira D; Department of Cancer Biology, Thomas Jefferson University, Philadelphia, PA, USA.
  • Ertel AE; Department of Cancer Biology, Thomas Jefferson University, Philadelphia, PA, USA.
  • Fortina P; Department of Cancer Biology, Thomas Jefferson University, Philadelphia, PA, USA.
  • Schwartz GF; Department of Surgery, Thomas Jefferson University, Philadelphia, PA, USA.
  • Knudsen ES; 1] Department of Pathology, UT Southwestern Medical Center, Dallas, TX, USA [2] Simmons Cancer Center, UT Southwestern Medical Center, Dallas, TX, USA.
Oncogene ; 33(30): 3980-91, 2014 Jul 24.
Article em En | MEDLINE | ID: mdl-24121271

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Proteína do Retinoblastoma / Carcinoma Intraductal não Infiltrante / Receptor ErbB-2 / Recidiva Local de Neoplasia Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Animals / Female / Humans Idioma: En Revista: Oncogene Ano de publicação: 2014 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Proteína do Retinoblastoma / Carcinoma Intraductal não Infiltrante / Receptor ErbB-2 / Recidiva Local de Neoplasia Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Animals / Female / Humans Idioma: En Revista: Oncogene Ano de publicação: 2014 Tipo de documento: Article